Zai Lab (ZLAB) Income from Continuing Operations (2020 - 2026)

Zai Lab's (ZLAB) quarterly Income from Continuing Operations came in at 51016000.0 in Q1 2026, down 5.32% year-on-year from 53883842.3 in Q1 2025, and down 1.2% quarter-over-quarter from 50409000.0 in Q4 2025.

Zai Lab (ZLAB) Income from Continuing Operations (2020 - 2026) Analysis & Trends

Zai Lab has disclosed Income from Continuing Operations across 7 years of filings, most recently posting 51016000.0 for Q1 2026.

  • Income from Continuing Operations for Q1 2026 came in at 51016000.0, down 5.32% year-over-year; the trailing twelve-month figure through Mar 2026 was 178115000.0 (up 29.34% YoY), and the FY2025 annual result was 175537000.0, up 31.73% from the prior year.
  • Income from Continuing Operations came in at 51016000.0 for Q1 2026 at Zai Lab, down from 50409000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 35963000.0 in Q3 2025 to a low of 161190000.0 in Q3 2022.
  • The 5-year median for Income from Continuing Operations is 61769000.0 (2022), against an average of 74196529.41.
  • Peak annual rise in Income from Continuing Operations reached 70.77% in 2022, while the deepest fall reached 67.78% in 2022.
  • Zai Lab's Income from Continuing Operations stood at 61769000.0 in 2022, then plunged by 54.49% to 95429000.0 in 2023, then climbed by 14.4% to 81684000.0 in 2024, then soared by 38.29% to 50409000.0 in 2025, then slipped by 1.2% to 51016000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 51016000.0 (Q1 2026), 50409000.0 (Q4 2025), and 35963000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.97 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 30.80 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.40 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -14.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.03 Bn
9 Abivax 91.96 Bn 91.96 Bn - -56.48 Mn
10 Zai Lab 20.15 Bn 20.05 Bn 61.30 Mn -51.02 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -51.02 Mn
Dec 31, 2025 -50.41 Mn
Sep 30, 2025 -35.96 Mn
Jun 30, 2025 -40.73 Mn
Mar 31, 2025 -48.44 Mn
Dec 31, 2024 -81.68 Mn
Sep 30, 2024 -41.67 Mn
Jun 30, 2024 -80.28 Mn
Mar 31, 2024 -53.47 Mn
Dec 31, 2023 -95.43 Mn
Sep 30, 2023 -69.15 Mn
Jun 30, 2023 -120.90 Mn
Mar 31, 2023 -49.14 Mn
Dec 31, 2022 -61.77 Mn
Sep 30, 2022 -161.19 Mn
Jun 30, 2022 -137.93 Mn
Mar 31, 2022 -82.17 Mn
Dec 31, 2021 -211.32 Mn
Sep 30, 2021 -96.07 Mn
Jun 30, 2021 -162.92 Mn